tomeko

Autosomal dominant optic atrophy plus syndrome

Just diagnosed with Autosomal dominant optic atrophy plus syndrome?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Autosomal dominant optic atrophy plus syndrome, look for clinical trials, and connect with others living with it — all in one place.

Open the full Autosomal dominant optic atrophy plus syndrome hub →

Overview

Autosomal dominant optic atrophy plus syndrome is a rare condition. Also known as ADOA+, DOA+, Optic atrophy-deafness-polyneuropathy-myopathy syndrome, Optic atrophy-hearing loss-polyneuropathy-myopathy syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for Autosomal dominant optic atrophy plus syndrome so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:1215 · OMIM 125250, 165199, 616648 · ICD-10 H47.2 · GARD 0005243

Find care for Autosomal dominant optic atrophy plus syndrome

Authoritative references for Autosomal dominant optic atrophy plus syndrome

Common questions

I was just diagnosed with Autosomal dominant optic atrophy plus syndrome — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Autosomal dominant optic atrophy plus syndrome, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Autosomal dominant optic atrophy plus syndrome?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Autosomal dominant optic atrophy plus syndrome, filtered to your area.

Are there clinical trials for Autosomal dominant optic atrophy plus syndrome?

Tomeko shows live, recruiting studies for Autosomal dominant optic atrophy plus syndrome from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com